Sally Brashears, Mark Kay, Jo Milner, Robert Lanford, David Russell, Robert Carithers, Emmet Keefe, Paul Pockros, Alexander Cappello, Christopher Miller, and Patricia Allen | GenomeWeb

Benitec announced last week a new management appointment, as well as the expansion of its scientific advisory board.

Sally Brashears has joined Benitec as vice president of intellectual property. According to the company, she previously served as a patent attorney with law firm Moser, Patterson, & Sheridan, and has also acted as director of IP for Clontech Laboratories and Perlagen Sciences. Brashears has also served as outside patent counsel to the National Stem Cell Centre, said Benitec.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.